Clinical Trials

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease

NCT05522387 2026-02-27

An Open-Label Extension of XPro1595 in Patients With Alzheimer's Disease

Phase 2 Terminated

11 enrolled

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Neurocognitive Disorders, Tauopathies

NCT05894954 2026-02-18

EVANTHEA

Phase 3 Completed

73 enrolled

Phase 2/3 Active not recruiting

Alzheimer Disease, Anomia, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06125951 2026-02-18

XanaMIA

247 enrolled

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT07415629 2026-02-17

Evaluation of a Self-compassion App in People With Cancer: Feasibility, Acceptability and Changes in Well-being

Phase NA Not yet recruiting

28 enrolled

Emotional Regulation, Alzheimer Disease, Neoplasms

NCT07392775 2026-02-06

ALDH2 Genetic Testing in East Asian Community

100 enrolled

Gastrointestinal

Alzheimer Disease, Cardiovascular Diseases, Esophageal Neoplasms, Flushing

NCT05637801 2026-02-05

Hope

670 enrolled

Phase NA Not yet recruiting

Alzheimer disease type 1, Alzheimer disease type 2, Alzheimer disease type 4, Alzheimer disease, familial, type 3, Alzheimer Disease 9, Alzheimer Disease 8, Alzheimer Disease 11, Alzheimer Disease 7, Alzheimer Disease 6, Alzheimer Disease 10, Alzheimer Disease 5, Alzheimer Disease 15, Alzheimer Disease 14, Alzheimer Disease 13, Alzheimer Disease 12, Alzheimer Disease 16, Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT07102212 2025-12-24

FOCUS

120 enrolled

BreastDermatologicGenitourinaryPlasma cellThoracic

Alzheimer Disease, Anxiety Disorders, Breast Neoplasms, Depression, Fatigue, Lung Neoplasms, Melanoma, Multiple Myeloma, Neoplasms, Prostatic Neoplasms

NCT06923501 2025-12-03

Evaluation of a Mobile App Program for Coping With Cancer

Phase NA Not yet recruiting

50 enrolled

Alzheimer Disease, Neoplasms

NCT06723015 2025-11-18

Tau PET Outcomes With Anti-amyloid Immunotherapies

Phase 2 Enrolling by invitation

135 enrolled

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT05425550 2025-09-22

PRO2

Phase NA Terminated

196 enrolled

Breast

Alzheimer Disease, Breast Neoplasms

NCT06804837 2025-08-26

Implement and Test Visual Consent Template and Process

515 enrolled

Alzheimer Disease, Neoplasms

NCT03282097 2025-08-11

DECAD

442 enrolled 13 charts

Breast

Alzheimer Disease, Breast Neoplasms

NCT06377033 2025-07-20

Using the EHR to Advance Genomic Medicine Across a Diverse Health System

1,000 enrolled

CNSEndocrine

Alzheimer Disease, Paraganglioma, Parkinson Disease, Pheochromocytoma, Polyneuropathies, Aortic Aneurysm, Thoracic, Genetic Predisposition to Disease, Frontotemporal Dementia

NCT04971733 2025-06-10

A Study to Assess Safety and Target Engagement of E2814 in Participants With Mild to Moderate Cognitive Impairment Due to Dominantly Inherited Alzheimer's Disease

Phase 1/2 Completed

8 enrolled 21 charts

CNSLymphoid

Alzheimer Disease, Central Nervous System Diseases, Lymphoma, Follicular

NCT07006155 2025-06-05

Biograph Vision 600 Versus Biograph Vision.X PET/CT

Phase 1 Not yet recruiting

40 enrolled

Alzheimer Disease, Neoplasms

NCT06644573 2025-05-28

PSHW

100 enrolled

Cancer Pain, Psychological Well-Being, Alzheimer Disease, Anxiety Disorders, Combat Disorders, Depression, Sleep Initiation and Maintenance Disorders, Pain, Sleep Deprivation, Stress Disorders, Post-Traumatic, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, REM Sleep Behavior Disorder, Chronobiology Disorders

NCT02939612 2025-03-20

Stress Management Intervention in Early Stage Cancer: Randomized Controlled Trial

200 enrolled

Alzheimer Disease, Neoplasms, Stress, Psychological

NCT05328115 2025-01-31

A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease

Phase 1 Completed

33 enrolled

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT04122235 2025-01-03

LETSGO

754 enrolled

Gynecologic

Empowerment, Alzheimer Disease, Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms

NCT04313582 2024-07-16

SmartPrompt

20 enrolled

Mixed Dementias, Alzheimer Disease, Dementia, Lymphoma, Follicular, Dementia, Vascular, Cognitive Dysfunction

NCT04315337 2024-07-16

VKI

16 enrolled

Mixed Dementias, Alzheimer Disease, Dementia, Lymphoma, Follicular, Dementia, Vascular, Cognitive Dysfunction

NCT06444841 2024-07-09

Paper-Based and Smartphone-Based Memory Supports

200 enrolled

Phase NA Enrolling by invitation

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT06245031 2024-05-07

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

402 enrolled

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT04531956 2024-01-23

S-DeciDeD

40 enrolled

Alzheimer Disease, Dementia, Lymphoma, Follicular

NCT06116084 2023-11-03

HYDEM

BreastGastrointestinalGenitourinary

100 enrolled

Alzheimer Disease, Myocarditis, Neoplasms

NCT02626377 2023-10-23

ICE

Phase NA Terminated

186 enrolled

Ischemic Stroke, Hemorrhagic Stroke, Alzheimer Disease, Breast Neoplasms, Heart Diseases, Macular Degeneration, Parkinson Disease, Prostatic Neoplasms, Colorectal Neoplasms

NCT05165186 2023-10-19

Care Planning for a Loved One With Dementia: Knowledge, Preparing for Decisions, and Emotions

150 enrolled

Caregiver Burden, Alzheimer Disease, Dementia, Lymphoma, Follicular, Pick Disease of the Brain, Frontotemporal Dementia

NCT05321498 2023-09-28

Study to Assess the Efficacy of XPro1595 in Patients With Mild Cognitive Impairment With Biomarkers of Inflammation

Phase 2 Withdrawn

CNS

Alzheimer Disease, Mental Disorders, Brain Diseases, Central Nervous System Diseases, Dementia, Inflammation, Nervous System Diseases, Neurodegenerative Diseases, Tauopathies, Cognitive Dysfunction

NCT05343611 2023-06-23

Choko-AGE

102 enrolled

Phase EARLY_PHASE1 Terminated

Frailty, Alzheimer Disease, Deficiency Diseases, Dementia, Lymphoma, Follicular, Motor Activity, Protein Deficiency, Malnutrition

NCT03371420 2023-04-18

PET Imaging of Subjects Using 124I-PU-AD

5 enrolled

LymphoidPlasma cell

Alzheimer Disease, Lymphoma, Neoplasms, Plasma Cell

NCT02742597 2023-03-17

PACEinMM-ON

GastrointestinalGenitourinaryHead & Neck

175 enrolled

Alzheimer Disease, Anxiety Disorders, Arthritis, Arthritis, Rheumatoid, Asthma, Cardiovascular Diseases, Ischemic Attack, Transient, Colitis, Ulcerative, Crohn Disease, Dementia, Depression, Diabetes Mellitus, Diverticulum, Gastroesophageal Reflux, Heart Failure, Hepatitis, Chronic, Hyperlipidemias, Hypertension, Kidney Diseases, Neoplasms, Osteoporosis, Thyroid Diseases, Ulcer, Stroke, Pulmonary Disease, Chronic Obstructive, Bronchitis, Chronic, Irritable Bowel Syndrome, Musculoskeletal Pain

NCT05613699 2022-11-14

YOUEX

106 enrolled

Alzheimer Disease, Fatigue, Motor Activity, Neoplasms

NCT04942184 2022-11-01

STRATEGIES to Improve Memory in Alzheimer's Disease

Phase NA Withdrawn

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT03236792 2022-09-29

Ixazomib In Combination With Cyclophosphamide And Dexamethasone for Newly Diagnosed AL Amyloidosis

Phase 1/2 Completed

28 enrolled

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease

NCT05407272 2022-06-08

Explore the Sharing Model Intervene to Improve the Knowledge, Attitudes, Service Intentions and Service Start-up Effects of the Eight Major Non-cancer Disease End-stage Caregivers on Well-being and Palliative Care

GastrointestinalGenitourinary

60 enrolled

Genitourinary

Alzheimer Disease, Fibrosis, Heart Failure, Kidney Failure, Chronic, Stroke, Pulmonary Disease, Chronic Obstructive, Acute Kidney Injury

NCT03721042 2022-04-14

OLFADIAG

Phase NA Terminated

68 enrolled

Alzheimer Disease, Stomach Neoplasms, Urologic Neoplasms

NCT04828434 2022-03-25

V-iCST

34 enrolled

Mixed Dementias, Alzheimer Disease, Dementia, Lymphoma, Follicular, Dementia, Vascular, Dementia, Multi-Infarct, Pick Disease of the Brain, Lewy Body Disease

NCT05150353 2021-12-09

AMYLOCARP

140 enrolled

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease

NCT03556280 2021-08-24

Overture

60 enrolled

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT01083316 2020-09-25

Bortezomib and Dexamethasone Followed by High-Dose Melphalan and Stem Cell Transplantation for Primary (AL) Amyloidosis

Phase 2 Completed

35 enrolled 9 charts

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis

NCT03384043 2020-07-08

Comparing Smartphone Technology and a Memory Strategy on Improving Prospective Memory in Alzheimer's Disease

52 enrolled

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT02986152 2019-11-26

Cancer Distress Coach Mobile App Trial

569 enrolled

Alzheimer Disease, Anxiety Disorders, Depression, Neoplasms, Stress Disorders, Post-Traumatic

NCT02902822 2019-05-17

Tele-dermatology of Skin Cancer in a Cohort of Local Health Authority Employees in the Province of Bergamo

461 enrolled

Dermatologic

Alzheimer Disease, Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Erysipelas, Herpes Zoster, Impetigo, Melanoma, Molluscum Contagiosum, Nevus, Tinea, Warts, Keratosis, Actinic

NCT02767609 2019-04-30

Measuring Cerebral Blood Flow Using Pseudo-continuous Arterial Spin Labeling Perfusion Magnetic Resonance Imaging

1 enrolled 4 charts

Brain Injuries, Traumatic, Alzheimer Disease, Multiple Sclerosis, Neoplasms

NCT02632786 2019-04-05

PRONTO

Phase 2 Completed

129 enrolled 18 charts

Immunoglobulin Light-chain Amyloidosis, Alzheimer Disease, Amyloidosis, Paraproteinemias

NCT02072252 2017-08-17

TODAY!

Phase 1/2 Withdrawn

Endocrine

Generalized Anxiety Disorder, Alzheimer Disease, Anxiety Disorders, Bisexuality, Depression, Homosexuality, Multiple Endocrine Neoplasia Type 1

NCT02859207 2017-06-08

A Study to Evaluate the Pharmacokinetics of E2609 and Its Metabolites in Subjects With Mild and Moderate Hepatic Impairment Compared With Healthy Subjects

Phase 1 Completed

32 enrolled

Alzheimer Disease, Lymphoma, Follicular

NCT00428090 2017-05-19

Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease

Phase 3 Completed

862 enrolled 36 charts